Antibiotics in intensive care: Too little or too much?

Critical Care Medicine

Volumn 39, Issue 7, 2011, Pages 1849-1851

  Johansen, Maria E ^a   Jensen, Jens Ulrik ^a,b   Lundgren, Jens D ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

antibiotic stewardship; noninferiority; procalcitonin; resistance; side effects

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 79959647835     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318215c0e2     Document Type: Editorial

References (14)

1. Heyland DK, Johnson AP, Reynolds SC, et al: Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation. Crit Care Med 2011; 39:1792-1799
2. Stocker M, Fontana M, El Helou S, et al: Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: Prospective randomized intervention trial. Neonatology 2010; 97:165-174
3. Schuetz P, Christ-Crain M, Thomann R, et al: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The Pro- HOSP randomized controlled trial. JAMA 2009; 302:1059-1066
4. Briel M, Schuetz P, Mueller B, et al: Procalcitonin- guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 2008; 168:2000 -2007; discussion 2007-2008
5. Gandhi TN, DePestel DD, Collins CD, et al: Managing antimicrobial resistance in intensive care units. Crit Care Med 2010; 38: S315-S323
6. Lawrence KL, Kollef MH: Antimicrobial stewardship in the intensive care unit: Advances and obstacles. Am J Respir Crit Care Med 2009; 179:434-438
7. Micek ST, Ward S, Fraser VJ, et al: A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125:1791-1799 (Pubitemid 38648413)
8. Spellberg B, Talbot GH, Brass EP, et al: Position paper: Recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis 2008; 47(Suppl 3):S249-S265
9. Wangge G, Klungel OH, Roes KC, et al: Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: A systematic review. PLoS One 2010; 5:e13550
10. Meisner M: Biomarkers of sepsis: Clinically useful? Curr Opin Crit Care 2005; 11: 473-480
11. Placebo controlled trial of sodium selenite and procalcitonin guided antimicrobial therapy in severe sepsis (SISPCT). Available at: , 2011
12. Safety and efficacy of procalcitonin guided antibiotic therapy in adult intensive care units (ICU's) (SAPS). Available at: http://www.clinicaltrials. gov/ct2/show/NCT01139489. Accessed February 4, 2011
13. Jensen J, Hein L, Lundgren J: Efficacy and Safety of Procalcitonin (PCT) Guided Antimicrobial Chemotherapy (AMC) in the Intensive Care Unit (ICU): Final Results from a Randomised Controlled Trial of 1,200 Patients. Presented at the Infectious Diseases Society of America Congress, Philadelphia, PA, October 28, 2009
14. Bouadma L, Luyt CE, Tubach F, et al: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010; 375:463-474